A case-control study of congenital abnormality and dimenhydrinate usage during pregnancy

Archives of Gynecology and Obstetrics

Volumn 271, Issue 2, 2005, Pages 113-118

  Czeizel, A E ^a   Vargha, P ^a  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Case control analysis; Congenital abnormalities; Dimenhydrinate; Human teratogenic potential; Nausea vomiting during pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ALLYLESTRENOL; AMINOPHYLLINE; AMPICILLIN; CLOTRIMAZOLE; DIAZEPAM; DIMENHYDRINATE; DROTAVERINE; METRONIDAZOLE; NITROFURANTOIN; NORAMIDOPYRINE; PENAMECILLIN; PHOLEDRINE; PROMETHAZINE; TERBUTALINE; THIETHYLPERAZINE;

ARTICLE; BIRTH CONTROL; BIRTH DEFECT; CONFIDENCE INTERVAL; FIRST TRIMESTER PREGNANCY; HEALTH SURVEY; HUMAN; OBSTRUCTIVE UROPATHY; PREGNANCY; RISK; STATISTICAL ANALYSIS; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTIEMETICS; CASE-CONTROL STUDIES; DIMENHYDRINATE; FEMALE; HUMANS; HUNGARY; PREGNANCY;

EID: 16444369646     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-004-0638-6     Document Type: Article

References (16)

1. Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in pregnancy and lactation, 5th edn. Williams and Wilkins, Baltimore
2. Czeizel AE (1997) The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 5:299-305
3. Czeizel AE, Rockenbauer M, Siffel CS, Varga E (2001) Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 63:176-185
4. Czeizel AE, Petik D, Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 12:409-416
5. Friedman JM, Polifka JE (1996) The effects of drugs on the fetus and nursing infant. Johns Hopkins University, Baltimore
6. Gross S, Librach C, Cecutti A (1989) Maternal weight loss associated with hyperemesis gravidarum: a predictor of fetal outcomes. Am J Obstet Gynecol 160:906-909
7. Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. John Wright - PSG, Littleton
8. McColl JD, Globus M, Robruson S (1965) Effect of some therapeutic agents in the developing rat fetus. Toxicol Appl Pharmacol 7:409-417
9. Mellin GW, Katzenstein M (1963) Meclozine and fetal abnormalities. Lancet 1:222-223
10. Mitchelson F (1992) Pharmacological agents affecting emesis. A review. I. Drugs 43:295-315
11. Mitchelson F (1992) Pharmacological agents affecting emesis. A review. II. Drugs 43:443-463
12. Nelson MM, Forfar JO (1971) Association between drugs administered during pregnancy and congenital abnormalities of the fetus. Br J Med 1:523-527
13. Rockenbauer J, Olsen J, Czeizel AE et al (2001) Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology 12:461-466
14. Shepard TH (1998) Catalog of teratogenic agents, 9th edn. Johns Hopkins University, Baltimore
15. Weigel RM, Weigel MM (1989) Nausea and vomiting of early pregnancy and pregnancy outcome. A meta-analytical review. Br J Obstet Gynecol 96:1312-1318
16. Yoo GD, Axelson JE, Taylor SM, Rurak DW (1986) Placental transfer of diphenhydramine in chronically instrumented pregnant sheep. J Pharm Sci 75:685-687